Cargando…
Evidence of acrolein in synovial fluid of dogs with osteoarthritis as a potential inflammatory biomarker
BACKGROUND: Acrolein is a known pro-inflammatory toxic aldehyde, propagating cellular damage and tissue inflammation in humans and animal models of various diseases. Osteoarthritis (OA) has a significant inflammatory component; however, presence of acrolein in synovial fluid of joints with OA has no...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529717/ https://www.ncbi.nlm.nih.gov/pubmed/34670524 http://dx.doi.org/10.1186/s12891-021-04762-z |
_version_ | 1784586526388125696 |
---|---|
author | Herr, Seth A. Malek, Sarah Rochat, Mark C. Moore, George E. Ko, Jeff C. Shi, Riyi |
author_facet | Herr, Seth A. Malek, Sarah Rochat, Mark C. Moore, George E. Ko, Jeff C. Shi, Riyi |
author_sort | Herr, Seth A. |
collection | PubMed |
description | BACKGROUND: Acrolein is a known pro-inflammatory toxic aldehyde, propagating cellular damage and tissue inflammation in humans and animal models of various diseases. Osteoarthritis (OA) has a significant inflammatory component; however, presence of acrolein in synovial fluid of joints with OA has not been previously reported. The first aim of this study was to evaluate evidence of acrolein in the synovial fluid of dogs with OA as well as in Control joints. The second aim was to determine if evidence of acrolein can be detected in synovial fluid samples that have been in a frozen state for long periods of time. METHODS: In this pilot clinical study, synovial fluid samples were prospectively collected (i.e., New samples) from a single joint of both clinically healthy (New Control, n = 5) and dogs with OA (New OA, n = 16) and frozen until the time of analysis. Additionally, frozen synovial fluid samples from a biobank (i.e., Old samples) were used to evaluate ability to detect evidence of acrolein in long-term stored samples (median of 4.89 years) in Old Control (n = 5) and Old OA (n = 5) samples. Measurements of acrolein in all synovial fluid samples was based on detection of its major protein adduct, N ε - (3-formyl-3, 4-dehydropiperidino)lysine (FDP-lysine), using the western blot method. Synovial fluid matrix metalloproteinase 2 (MMP2) was measured in all samples using the western blot method as a positive control of OA inflammation. RESULTS: Acrolein-lysine adduct was detected in both Control (n = 10) and OA (n = 21) groups in both Old and New samples. Acrolein-lysine adduct and MMP2 were detectable at a lower level in the Old compared to New synovial fluid samples; however, the differences were not statistically significant (p > 0.1). The measured MMP2 levels were significantly higher in the OA compared to Control group samples (p = 0.033), but not for acrolein-lysine adduct (p = 0.30). CONCLUSIONS: This study confirmed evidence of acrolein in canine synovial fluid of both OA and Control groups. Freezing of synovial fluid for up to 5 years does not appear to significantly affect the ability to detect acrolein-lysine adduct and MMP2 in these samples. |
format | Online Article Text |
id | pubmed-8529717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85297172021-10-25 Evidence of acrolein in synovial fluid of dogs with osteoarthritis as a potential inflammatory biomarker Herr, Seth A. Malek, Sarah Rochat, Mark C. Moore, George E. Ko, Jeff C. Shi, Riyi BMC Musculoskelet Disord Research BACKGROUND: Acrolein is a known pro-inflammatory toxic aldehyde, propagating cellular damage and tissue inflammation in humans and animal models of various diseases. Osteoarthritis (OA) has a significant inflammatory component; however, presence of acrolein in synovial fluid of joints with OA has not been previously reported. The first aim of this study was to evaluate evidence of acrolein in the synovial fluid of dogs with OA as well as in Control joints. The second aim was to determine if evidence of acrolein can be detected in synovial fluid samples that have been in a frozen state for long periods of time. METHODS: In this pilot clinical study, synovial fluid samples were prospectively collected (i.e., New samples) from a single joint of both clinically healthy (New Control, n = 5) and dogs with OA (New OA, n = 16) and frozen until the time of analysis. Additionally, frozen synovial fluid samples from a biobank (i.e., Old samples) were used to evaluate ability to detect evidence of acrolein in long-term stored samples (median of 4.89 years) in Old Control (n = 5) and Old OA (n = 5) samples. Measurements of acrolein in all synovial fluid samples was based on detection of its major protein adduct, N ε - (3-formyl-3, 4-dehydropiperidino)lysine (FDP-lysine), using the western blot method. Synovial fluid matrix metalloproteinase 2 (MMP2) was measured in all samples using the western blot method as a positive control of OA inflammation. RESULTS: Acrolein-lysine adduct was detected in both Control (n = 10) and OA (n = 21) groups in both Old and New samples. Acrolein-lysine adduct and MMP2 were detectable at a lower level in the Old compared to New synovial fluid samples; however, the differences were not statistically significant (p > 0.1). The measured MMP2 levels were significantly higher in the OA compared to Control group samples (p = 0.033), but not for acrolein-lysine adduct (p = 0.30). CONCLUSIONS: This study confirmed evidence of acrolein in canine synovial fluid of both OA and Control groups. Freezing of synovial fluid for up to 5 years does not appear to significantly affect the ability to detect acrolein-lysine adduct and MMP2 in these samples. BioMed Central 2021-10-20 /pmc/articles/PMC8529717/ /pubmed/34670524 http://dx.doi.org/10.1186/s12891-021-04762-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Herr, Seth A. Malek, Sarah Rochat, Mark C. Moore, George E. Ko, Jeff C. Shi, Riyi Evidence of acrolein in synovial fluid of dogs with osteoarthritis as a potential inflammatory biomarker |
title | Evidence of acrolein in synovial fluid of dogs with osteoarthritis as a potential inflammatory biomarker |
title_full | Evidence of acrolein in synovial fluid of dogs with osteoarthritis as a potential inflammatory biomarker |
title_fullStr | Evidence of acrolein in synovial fluid of dogs with osteoarthritis as a potential inflammatory biomarker |
title_full_unstemmed | Evidence of acrolein in synovial fluid of dogs with osteoarthritis as a potential inflammatory biomarker |
title_short | Evidence of acrolein in synovial fluid of dogs with osteoarthritis as a potential inflammatory biomarker |
title_sort | evidence of acrolein in synovial fluid of dogs with osteoarthritis as a potential inflammatory biomarker |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529717/ https://www.ncbi.nlm.nih.gov/pubmed/34670524 http://dx.doi.org/10.1186/s12891-021-04762-z |
work_keys_str_mv | AT herrsetha evidenceofacroleininsynovialfluidofdogswithosteoarthritisasapotentialinflammatorybiomarker AT maleksarah evidenceofacroleininsynovialfluidofdogswithosteoarthritisasapotentialinflammatorybiomarker AT rochatmarkc evidenceofacroleininsynovialfluidofdogswithosteoarthritisasapotentialinflammatorybiomarker AT mooregeorgee evidenceofacroleininsynovialfluidofdogswithosteoarthritisasapotentialinflammatorybiomarker AT kojeffc evidenceofacroleininsynovialfluidofdogswithosteoarthritisasapotentialinflammatorybiomarker AT shiriyi evidenceofacroleininsynovialfluidofdogswithosteoarthritisasapotentialinflammatorybiomarker |